OBD vs. FUM, COS, C4XD, DDDD, TRX, SAR, AREC, OKYO, AOR, and FAB
Should you be buying Oxford BioDynamics stock or one of its competitors? The main competitors of Oxford BioDynamics include Futura Medical (FUM), Collagen Solutions plc (COS.L) (COS), C4X Discovery (C4XD), 4D pharma (DDDD), Tissue Regenix Group (TRX), Sareum (SAR), Arecor Therapeutics (AREC), OKYO Pharma (OKYO), AorTech International (AOR), and Fusion Antibodies (FAB). These companies are all part of the "biotechnology" industry.
Oxford BioDynamics vs. Its Competitors
Oxford BioDynamics (LON:OBD) and Futura Medical (LON:FUM) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, risk, profitability, media sentiment, valuation, analyst recommendations and earnings.
Oxford BioDynamics has a beta of 0.42, meaning that its share price is 58% less volatile than the S&P 500. Comparatively, Futura Medical has a beta of 1.25, meaning that its share price is 25% more volatile than the S&P 500.
Futura Medical has higher revenue and earnings than Oxford BioDynamics. Futura Medical is trading at a lower price-to-earnings ratio than Oxford BioDynamics, indicating that it is currently the more affordable of the two stocks.
44.3% of Oxford BioDynamics shares are owned by institutional investors. Comparatively, 35.7% of Futura Medical shares are owned by institutional investors. 16.8% of Oxford BioDynamics shares are owned by insiders. Comparatively, 32.1% of Futura Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
In the previous week, Futura Medical had 1 more articles in the media than Oxford BioDynamics. MarketBeat recorded 1 mentions for Futura Medical and 0 mentions for Oxford BioDynamics. Oxford BioDynamics' average media sentiment score of 0.00 equaled Futura Medical'saverage media sentiment score.
Futura Medical has a net margin of -44.64% compared to Oxford BioDynamics' net margin of -1,800.32%. Futura Medical's return on equity of -56.44% beat Oxford BioDynamics' return on equity.
Summary
Futura Medical beats Oxford BioDynamics on 10 of the 12 factors compared between the two stocks.
Get Oxford BioDynamics News Delivered to You Automatically
Sign up to receive the latest news and ratings for OBD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding OBD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Oxford BioDynamics Competitors List
Related Companies and Tools
This page (LON:OBD) was last updated on 8/23/2025 by MarketBeat.com Staff
MarketBeat All Access